Alarin-mediated pleiotropic NPY release from hypothalamic explants directly enters into the adipose tissue by activating NPY-Y2 receptors to influence GLUT4 mRNA expression in adipocytes of subjects as well as to accelerate glucose intake that stimulates appetite and obesity (5, 47). The gene discussed is NPY; the disease is Obesity.